189. Fetal Alcohol Spectrum Disorders: Recognition Matters

Are you unwittingly overlooking a silent epidemic affecting newborns right under your nose? This game-changing episode of Pediatric Meltdown will redefine everything you thought you knew about molding young minds. We delve deep into the world of FASD (Fetal Alcohol Spectrum Disorders) and the critical need for timely screening at newborn visits. Hosted by Dr. Lia Gaggino, we dive into the transformative world of the oft-missed signs of fetal alcohol spectrum disorders and the life-altering implications they hold. Uncover the resources every parent and pediatrician should have at their fingertips, the surprising truth about the plasticity of the brain, and the lifeline that support groups offer to families navigating this challenging journey. It’s clear that understanding and addressing ND PAE requires ongoing effort and awareness. The valuable insights shared in this episode are bolstered by the wealth of resources and guidance provided by organizations such as the American Academy of Pediatrics (AAP). Through Pediatric Meltdown, we aim to bring this critical information to the forefront, equipping practitioners and families with the know-how to usher in positive change. Tune in to hear how this episode promises to reveal a groundbreaking approach recommended by the AAP that could turn the tide in the ongoing battle against pediatric mental health challenges. Don't miss out – your next step in pediatric care innovation could be just one listen away!     [05:30-12:44]  Understanding FASD and Its ImpactDefinition and prevalence of FASD, including the sobering statistic that it affects 1 in 40 children.Prenatal alcohol exposure significantly affects the brain, especially the hippocampus and amygdala, causing developmental challenges.A look at the physical features associated with FAS, highlighting the preventability of this condition.Recognizing FASD early is crucial for intervention and leveraging the brain's adaptability for better outcomes with help.[12:45-22:14] Screening and Prevention Strategies   The necessity of nonjudgmental surveillance questions at newborn visits to screen for ND PAE.discussing alcohol use with patients before and during pregnancy to avoid guilt and stigma affecting truthful disclosure.The roles of obstetricians and pediatricians in fostering ongoing dialogues about the risks of alcohol consumption.Prevention measures and education for adolescents and women of fertility age, aiming to mitigate the prevalence of FASD.[22:15-34:09] Resources for Clinicians and ParentsInformation on available resources from AAP, NOFAS, CDC, and NIMH for diagnosis and parental support.Recommendations for referring to developmental behavioral pediatricians or child psychiatry access programs.The utility of early intervention services for children with suspected ND PAE.Advocation for parent support groups as a means of providing guidance and comfort[34:10 - 50:48] Medications and InterventionsDiscussion on medications used for FASD, with particular emphasis on ADHD and mood-stabilizing medications.The debated effectiveness of non-stimulant medications like alpha agonists for children with ND PAE.Tips on prescribing medications appropriately, with support from programs like ECHO.Insights into the specific challenges faced by children with FASD, including attention to detail issues and difficulty with self-soothing.[50:49 - 59:11]  Closing segment TakeawayLinks to resources mentioned on the showAAP Toolkit: <a href="https://www.aap.org/en/patient-care/fetal-alcohol-spectrum-disorders/"

Fecha de Publicación: 10 de abril de 2024

Duración: 59 min